Related Experiment Video
Updated: Jun 17, 2026

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
Irritable bowel syndrome: a population based study
Babak Khoshkrood-Mansoori1, Mohamad Amin Pourhoseingholi, Azadeh Safaee
1Department of Health System Research, Research Center for Gastroenterology and Liver Disease, Shahid Beheshti University (M.C), Tehran, Iran.
The prevalence of Irritable Bowel Syndrome (IBS) in Iran is low at 1.1% using ROME III criteria. This study highlights the importance of diagnostic criteria in population-based research.
Area of Science:
- Gastroenterology
- Epidemiology
- Public Health
Background:
- Irritable Bowel Syndrome (IBS) has a high prevalence globally.
- No prior population-based studies in Iran utilized the ROME III criteria for IBS diagnosis.
- Understanding IBS prevalence is crucial for public health initiatives.
Purpose of the Study:
- To determine the prevalence of IBS in the adult population of Iran.
- To apply the ROME III diagnostic criteria in a large-scale Iranian study.
- To identify demographic factors associated with IBS in Iran.
Main Methods:
- A face-to-face survey was conducted in the Tehran province.
- A validated questionnaire based on the ROME III criteria was used for IBS diagnosis.
- The study included 18,180 adult participants.
Main Results:
- The overall prevalence of IBS was found to be 1.1% (139 women, 59 men).
- IBS patients were more likely to be married and older.
- Predominant symptoms included abdominal pain relieved by defecation (94%), altered fecal consistency (78%), and altered bowel frequency (70%).
Conclusions:
- The prevalence of IBS in the Iranian adult population is relatively low based on ROME III criteria.
- The specificity of the ROME III criteria may contribute to the observed low prevalence.
- A low prevalence of gastrointestinal symptoms in the study population is a potential factor.
Related Concept Videos
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome
Irritable Bowel Syndrome III: Medical and Nursing Management
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
